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natural tensions derived from different advocacies
meet and are able to work out solutions to the
problems posed by modern medicine while man-
aging to surveil on each other’s constraint.
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EDITORIAL
Practice guidelines by specialist societies are surprisingly
deﬁcient
The term evidence-based implies that it is suppor-
ted by data from randomised controlled trials
(RCTs). RCTs, if conducted and reported correctly,
are accepted as the best way to conﬁdently know
the beneﬁts and harms of an intervention. When
purportedly evidence-based guidelines and recom-
mendations stray from this principle, they should
no longer be able to call them evidence-based. So
much of the evidence-based paradigm is missing
from the Joint British Societies Guidelines on Pre-
vention of Cardiovascular Disease in Clinical Prac-
tice (JBS-2) that the author critiquing them has
entitled his article ‘Eminence Based Guideline’ (1).
The use of the word ‘eminence’ seems particularly
appropriate, as it connotes the ‘arrogance’ that
seems to be an invariable part of guidelines based
on expert opinion (2). The JBS-2 guidelines score
low on most of the main quality criteria according
to the AGREE instrument (3): stakeholders’
involvement, rigour of development, applicability
and editorial independence. This is not the ﬁrst
time that specialist societies’ clinical practice guide-
lines have been found deﬁcient; however, it surpri-
sing that guideline rigour and quality is not
improving.
Clinical practice guidelines came about when spe-
cialists were asked to give their opinions and guid-
ance as to best practice in an attempt to decrease
unacceptable variability and cost inefﬁciencies in
clinical practice. Not surprisingly, this proved inad-
equate and often irrelevant to the problems encoun-
tered in primary care. The evidence-based medicine
movement arose to provide some evidential basis
behind guideline recommendations. The result has
been some improvement in the validity and reliabil-
ity of most guidelines, but unfortunately this has
not had much impact on clinical practice (4). Why
is that the case? In my opinion one of the reasons
is because guideline writers are unable to overcome
their own ‘arrogance’ that they can provide ‘aggres-
sively assertive’ guidance despite lack of evidence
(2). The attempt by guideline writers to make the
rationale behind the decision process more trans-
parent by grading the recommendations has not
worked. Readers of guidelines do not distinguish
between grade A, level 1, grade B, level 2 recom-
mendations and grade C, level 4 recommendations.
In my experience, when doctors ﬁnd any recom-
mendations in guidelines inconsistent with their
own clinical practice, they become sceptical about
all of them. Furthermore as long as guidelines con-
tinue to be funded by companies and written by
individuals with competing interests, they lack cre-
dibility (5). This sad situation is certainly not
helped when guidelines, such as JBS-2, are pro-
duced that after evaluation are judged as in Minhas’
article: ‘of low quality and should not be recom-
mended for clinical practice’ (1).
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the best way forward is to return to the ﬁrst princi-
ple. Guidelines should limit their recommendations
to the interventions and patient populations that are
supported by high quality evidence from RCTs. This
approach has many advantages: (i) recommendations
would be supported by RCTs and systematic reviews;
(ii) there would be no necessity to grade recommen-
dations; (iii) recommendations would be fewer and
less subject to bias; (iv) recommendations would be
more likely to be followed, because they are fewer
and better supported; (v) time and effort to produce
guidelines would be less and (vi) clinical settings
with no recommendations would be identiﬁed as
requiring RCTs. Following this ﬁrst principle, cardio-
vascular guidelines would not make recommenda-
tions regarding lipid targets or blood pressure targets
as was done by JBS-2; RCTs are badly needed to
determine optimal treatment targets for both lipids
and blood pressure. I am not suggesting that it is
always easy to determine when RCT evidence is clear
enough to make a strong recommendation. There
will still be recommendations that are open to
debate, and this would be healthy. I am also aware
that the methods of evaluating guidelines, including
the AGREE instrument (3) used by Minhas could be
improved. I am suggesting that physicians and
patients deserve truly evidence-based guidelines and
not ‘eminence’-based guidelines, and I am hopeful
that by putting forward this provocative proposal
that I can help to discourage guideline recommenda-
tions based on expert (eminent) opinion.
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